Reneo Pharmaceuticals Raises $95 Million in Series B Financing, Co-led by Novo Ventures and AbingworthDecember 9, 2020 Learn More
Reneo Receives Orphan Drug Designations from the EMA for REN001 for the Treatment of LCHAD Deficiency and MELAS Syndrome and Moves Forward with Clinical TrialsSeptember 9, 2020 Learn More
Restoring Cellular Power Outages: A New Drug Candidate to Treat Mitochondrial DiseaseAugust 12, 2020 Learn More
